Celon Pharma S.A. (WSE:CLN)
Poland · Delayed Price · Currency is PLN 22.35
+0.15 (0.68%)
Sep 5, 2025, 5:00 PM CET
Celon Pharma Market Cap
Celon Pharma has a market cap or net worth of 1.20 billion as of September 5, 2025. Its market cap has decreased by -16.91% in one year.
Market Cap
1.20B
Enterprise Value
1.17B
Revenue
215.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.35
Market Cap Chart
Since December 1, 2016, Celon Pharma's market cap has increased from 1.00B to 1.20B, an increase of 20.06%. That is a compound annual growth rate of 2.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 1.20B | -15.50% |
| Dec 30, 2024 | 1.42B | 80.47% |
| Dec 29, 2023 | 789.33M | 10.32% |
| Dec 30, 2022 | 715.51M | -57.68% |
| Dec 30, 2021 | 1.69B | -7.35% |
| Dec 30, 2020 | 1.82B | 2.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.79B |
| NEUCA | 3.09B |
| Synektik Spólka Akcyjna | 2.06B |
| Voxel | 1.74B |
| Ryvu Therapeutics | 642.74M |
| Selvita | 583.70M |
| Centrum Medyczne ENEL-MED | 506.22M |
| Bioceltix | 472.75M |